"Title to come"

Speaker: Shawn Demehri, M.D., Ph.D., Associate Professor of Dermatology (Cutaneous Biology Research Center), Mass General Cancer Center, Harvard Medical School

Date: Apr. 17, 2025, 4:30-5:30 p.m.

Location: Roy Blunt NextGen Precision Health Building, Atkins Family Seminar Room

*Zoom option available 

Register Here

About the Speaker

The focus of the Demehri laboratory is to determine the role of the immune system in regulating the early stages of cancer development in order to harness its anti-tumor potential for cancer therapy. To date, several cancer immunotherapies have been developed with proven efficacy against late-stage cancers; however, the role of the immune system in preventing the early development of cancer remains uncertain. The research in our laboratory is focused on identifying the immune mechanisms that drive an immune activation sufficient to prevent cancer formation from pre-cancerous lesions. This approach raises a great opportunity to discover novel immune pathways that can be leveraged in cancer therapy and prevention.

About the Series

The goal of the NextGen Precision Health & Ellis Fischel Cancer Center Science Seminar is to highlight transdisciplinary precision research taking place in the cancer field, provide opportunities for collaboration among researchers to build their own research efforts and promote clinical/researcher activity across the University of Missouri System and our partners.

For questions about this event, please reach out to Mackenzie Lynch.